It was not exactly “sell in May and go away” as the S&P 500 climbed 1.1% this month while the Nasdaq Composite climbed almost 2.6%, but U.S. stocks did finish the month on a down note. The last week of May brought the first weekly decline in four for U.S. equities.
Slack U.S. economic data and lingering fears about Greece’s tenuous grasp on Eurozone membership were among the factors weighing on stocks this week. As is always the case, it was an interesting week for exchange traded, including it being one of the busiest weeks for new product launches in quite a while. With that, we’ll get into some of the week’s biggest ETF stories.
Broad Market/Sector ETFs
For the adventurous (and risk-tolerant), triple-leveraged biotech ETFs are here. [Triple-Leveraged Biotech ETFs Have Arrived]
A big healthcare ETF is ready to deliver more big returns.
Reasons to be chipper on chip ETFs. [Good Reasons to bet on Semiconductor ETFs]
Biotech ETFs are not out for summer. [Biotech ETFs Could be hot This Summer]
Plenty of good reasons to keep low volatility ETFs on watch.
An ETF for companies that reinvest in their businesses. [New CapEx ETF Comes to Town]